2.965
price down icon0.84%   -0.025
after-market Dopo l'orario di chiusura: 2.97 0.005 +0.17%
loading

Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie

pulisher
Mar 25, 2026

Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (NASDAQ: LIXT) Saw It Coming - USA Today

Mar 25, 2026
pulisher
Mar 25, 2026

Treasury Yields: Can Lixte Biotechnology Holdings Inc Equity Warrant sustain its profitabilityEarnings Growth Summary & Fast Momentum Entry Tips - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

Pharma News: Whats the profit margin of Lixte Biotechnology Holdings IncStock Surge & Safe Capital Growth Trade Ideas - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 23, 2026

LIXTE Biotechnology (LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape - NewMediaWire

Mar 23, 2026
pulisher
Mar 23, 2026

LIXTE Biotechnology (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape - TipRanks

Mar 23, 2026
pulisher
Mar 21, 2026

Market Fear: Can Lixte Biotechnology Holdings Inc. Equity Warrant be recession proofFed Meeting & Fast Entry and Exit Trade Plans - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Lixte Biotechnology Raises CEO Compensation Amid Leadership Support - TipRanks

Mar 20, 2026
pulisher
Mar 20, 2026

Lixte (NASDAQ: LIXT) lifts CEO Geordan Pursglove base salary to $360k - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

Lixte Biotechnology boosts CEO Geordan Pursglove's base salary to $360,000 - TradingView

Mar 20, 2026
pulisher
Mar 20, 2026

Lixte Biotechnology stock faces scrutiny amid stalled pipeline progress and biotech sector volatilit - AD HOC NEWS

Mar 20, 2026
pulisher
Mar 18, 2026

Lixte Biotechnology shares slide following purchase of UK-based Liora - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Guidance Update: Is Lixte Biotechnology Holdings Inc a stock for growth or value investorsWeekly Gains Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Breakout Move: Can Lixte Biotechnology Holdings Inc Equity Warrant be recession proofWeekly Profit Report & Safe Capital Growth Plans - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Lixte Biotechnology Stock (ISIN: US53833K1060) Faces Short-Term Pressure Amid Strong Rising Trend an - AD HOC NEWS

Mar 17, 2026
pulisher
Mar 17, 2026

Bond Watch: Does Lixte Biotechnology Holdings Inc align with a passive investing strategyOil Prices & Daily Stock Trend Watchlist - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

LIXTE Biotechnology and Liora Technologies Partner to Advance Combined Cancer Treatment Approach - citybuzz -

Mar 16, 2026
pulisher
Mar 16, 2026

Aug PostEarnings: Can Lixte Biotechnology Holdings Inc Equity Warrant be recession proof2026 Intraday Action & Stock Portfolio Risk Control - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 15, 2026

Lixte Biotechnology Stock (ISIN: US53833K1060) Trades Steadily Amid Clinical-Stage Oncology Focus - AD HOC NEWS

Mar 15, 2026
pulisher
Mar 13, 2026

Is Lixte Biotechnology Holdings Inc stock technically oversold2026 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Mar 13, 2026
pulisher
Mar 13, 2026

LIXTE Biotechnology Expands Ovarian Cancer Trial Through MD Anderson and GSK Partnership - citybuzz -

Mar 13, 2026
pulisher
Mar 11, 2026

Lixte Amends Share Exchange, Clarifies Liora Ownership Structure - The Globe and Mail

Mar 11, 2026
pulisher
Mar 10, 2026

Lixte Biotechnology Enters Amended Share Exchange to Consolidate Liora Ownership With Orbit Capital - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

Lixte (NASDAQ: LIXT) restates Liora share exchange and Orbit’s 20% stake - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

LIXTE Biotechnology Holdings (LIXT) Adds Innovative LiGHT Therapy to Pipeline - Yahoo Finance

Mar 10, 2026
pulisher
Mar 10, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline - TipRanks

Mar 10, 2026
pulisher
Mar 09, 2026

LIXTE Biotechnology (LIXT) Advances Lead Compound in Tumor Immunogenicity Research - NewMediaWire

Mar 09, 2026
pulisher
Mar 09, 2026

LIXTE Biotechnology (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Research - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

Powell Max Limited Successfully Repositions for Its Next Phase of Growth - The Manila Times

Mar 09, 2026
pulisher
Mar 07, 2026

Aug Sectors: Whats the profit margin of Lixte Biotechnology Holdings IncWeekly Profit Recap & Capital Efficient Trading Techniques - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Trade Report: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantWeekly Gains Summary & Technical Entry and Exit Alerts - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Volatility Watch: What is the next catalyst for Lixte Biotechnology Holdings Inc Equity WarrantWeekly Stock Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Why Lixte Biotechnology Holdings Inc. stock attracts high net worth investorsMarket Risk Analysis & Safe Entry Point Alerts - Naître et grandir

Mar 06, 2026
pulisher
Mar 06, 2026

Wall Street Recap: Why is Lixte Biotechnology Holdings Inc Equity Warrant stock going downDollar Strength & Risk Controlled Daily Plans - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

MACD Signal: How does Lixte Biotechnology Holdings Inc Equity Warrant perform in inflationary periodsTrade Analysis Report & Low Risk Growth Stock Ideas - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

LIXTW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Mar 02, 2026

LIXTE Biotechnology (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - Digital Journal

Mar 02, 2026
pulisher
Mar 02, 2026

LIXTE Biotechnology (NASDAQ: LIXT) Aligns Liora and LiGHT System With LB-100 to Push Frontier of Cancer Treatment - Digital Journal

Mar 02, 2026
pulisher
Feb 28, 2026

Downgrade Watch: Will Lixte Biotechnology Holdings Inc stock go up in YEARJuly 2025 Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn

Feb 28, 2026
pulisher
Feb 27, 2026

Should I Buy LIXT? LIXT 2026 AnalysisIntellectia AI™ - Intellectia AI

Feb 27, 2026
pulisher
Feb 25, 2026

LIXTWLixte Biotechnology Hldgs Inc Latest Stock News & Market Updates - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - USA Today

Feb 25, 2026
pulisher
Feb 25, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - USA Today

Feb 25, 2026
pulisher
Feb 21, 2026

Should I invest in Lixte Biotechnology Holdings Inc. before earningsJuly 2025 Chart Watch & Expert Approved Trade Ideas - mfd.ru

Feb 21, 2026
pulisher
Feb 21, 2026

Is Lixte Biotechnology Holdings Inc. stock a value trap2025 Stock Rankings & Accurate Entry and Exit Point Alerts - mfd.ru

Feb 21, 2026
pulisher
Feb 20, 2026

Why Lixte Biotechnology Holdings Inc. stock could rally in 2025July 2025 WrapUp & Precise Swing Trade Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

What is the next catalyst for Lixte Biotechnology Holdings Inc. Equity WarrantWeekly Loss Report & Verified Trade Idea Suggestions - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Will Lixte Biotechnology Holdings Inc. stock go up in YEARJuly 2025 Summary & Community Verified Trade Signals - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary By Investing.com - Investing.com India

Feb 19, 2026
pulisher
Feb 18, 2026

LIXTE Biotechnology (LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary - NewMediaWire

Feb 18, 2026
pulisher
Feb 18, 2026

Lixte Elevates Liora Leadership to Advance Proton Therapy - TipRanks

Feb 18, 2026
pulisher
Feb 18, 2026

LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary - Investing.com

Feb 18, 2026
pulisher
Feb 18, 2026

Lixte Biotechnology appoints Sidney Braun as CEO, Liora - TipRanks

Feb 18, 2026
$27.35
price down icon 0.04%
$46.94
price down icon 0.19%
$53.57
price up icon 0.06%
$87.46
price down icon 1.48%
ONC ONC
$276.95
price down icon 2.29%
$147.60
price down icon 0.48%
Capitalizzazione:     |  Volume (24 ore):